These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25779551)

  • 1. Systemic methotrexate for the treatment of psoriasis.
    Yélamos O; Puig L
    Expert Rev Clin Immunol; 2015 May; 11(5):553-63. PubMed ID: 25779551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of methotrexate in patients with psoriasis.
    Kuhn A; Ruland V; Patsinakidis N; Luger TA
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S138-44. PubMed ID: 21044448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate: new therapeutic approaches.
    Puig L
    Actas Dermosifiliogr; 2014; 105(6):583-9. PubMed ID: 23434058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic methotrexate therapy for psoriasis: past, present and future.
    Dogra S; Mahajan R
    Clin Exp Dermatol; 2013 Aug; 38(6):573-88. PubMed ID: 23837932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and systemic therapy.
    van de Kerkhof P
    Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A; Tan E; Ilchyshyn A; Berth-Jones J
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.
    Montaudié H; Sbidian E; Paul C; Maza A; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():12-8. PubMed ID: 21388454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nail psoriasis successfully treated with intralesional methotrexate: case report.
    Sarıcaoglu H; Oz A; Turan H
    Dermatology; 2011 Feb; 222(1):5-7. PubMed ID: 21228554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting.
    Rademaker M; Gupta M; Andrews M; Armour K; Baker C; Foley P; Gebauer K; George J; Rubel D; Sullivan J
    Australas J Dermatol; 2017 Aug; 58(3):166-170. PubMed ID: 27402434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methotrexate therapy in psoriasis].
    Bournerias I
    Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic.
    Barker J; Horn EJ; Lebwohl M; Warren RB; Nast A; Rosenberg W; Smith C;
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):758-64. PubMed ID: 21198946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis.
    Warren RB; Smith RL; Campalani E; Eyre S; Smith CH; Barker JN; Worthington J; Griffiths CE
    J Invest Dermatol; 2008 Aug; 128(8):1925-9. PubMed ID: 18256692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW; Weinstein GD
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
    Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of Methotrexate in psoriasis: an eight-year experience with 218 patients.
    Cabello Zurita C; Grau Pérez M; Hernández Fernández CP; González Quesada A; Valerón Almazán P; Vilar Alejo J; Carretero Hernández G
    J Dermatolog Treat; 2017 Aug; 28(5):401-405. PubMed ID: 28001499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the effect of narrowband ultraviolet B phototherapy plus methotrexate vs. narrowband ultraviolet B alone and methotrexate alone in the treatment of plaque-type psoriasis.
    Al-Hamamy HR; Al-Mashhadani SA; Mustafa IN
    Int J Dermatol; 2014 Dec; 53(12):1531-5. PubMed ID: 24738793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subcutaneous methotrexate in psoriasis and psoriatic arthritis treatment].
    Szczerkowska-Dobosz A
    Wiad Lek; 2016; 69(4):675-679. PubMed ID: 27941209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX-CAPTURE.
    Otero ME; van den Reek JM; Seyger MM; van de Kerkhof PC; Kievit W; de Jong EM
    Br J Dermatol; 2017 Aug; 177(2):497-504. PubMed ID: 28078672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.
    Baran W; Batycka-Baran A; Zychowska M; Bieniek A; Szepietowski JC
    Expert Opin Drug Saf; 2014 Aug; 13(8):1015-21. PubMed ID: 24972718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy of psoriasis using methotrexate.
    Smith KC
    Skin Therapy Lett; 2000; 6(3):1-2; 5. PubMed ID: 11176041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.